Home / Companies / Royalty Pharma Plc / 4 Jun 2026
Royalty Pharma Plc: meeting of 4 Jun 2026
Votes reported on Form N-PX, item by item
750 Form N-PX filers reported votes at the Royalty Pharma Plc meeting of 4 Jun 2026. Their records fall into 8 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
9 nominees; 94.1% of reported votes for; 59 filers withheld from or voted against at least one nominee.
4,315 vote records from 201 filers. 2 of the 201 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
1,274 vote records from 746 filers. 27 of the 716 filers that marked the item either way voted against management. 30 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
1,443 vote records from 201 filers. 1 of the 201 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
1,409 vote records from 199 filers. 2 of the 199 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
444 vote records from 191 filers. 3 of the 190 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
430 vote records from 165 filers. 1 of the 165 filers that marked the item either way voted against management.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
60 vote records from 33 filers. 0 of the 33 filers that marked the item either way voted against management.
Several categoriesSecurity holder
Shareholder proposals (not separable from the filings)
Filers described these proposals in wordings that could not be matched to one another, so they are shown together.
9 vote records from 1 filers. 0 of the 1 filers that marked the item either way voted against management.
How the largest families voted
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Royalty Pharma Plc meeting?
750 Form N-PX filers reported votes at the meeting of 4 Jun 2026. On say-on-pay, 27 of 716 voted against management (3.8%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Royalty Pharma Plc on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Royalty Pharma Plc
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Royalty Pharma Plc with a meeting date within three days of 4 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.